Health Care / Hospitals
Releases published in the last 30 days. 
Page 1 of 3
- Final Day to Download “Say No to Chronic Inflammation” Free — Guide Helps Adults Boost Energy, Mobility, Sleep, and Support Healthy Aging
- 1/17/2026
- Today is the final day for readers to download “Say No to Chronic Inflammation: A Simple 6-Step Plan to Calm the Fire and Heal Your Body” for free during its launch promotion on Amazon Kindle.
- Allegations related to Medicare risk adjustment resolved
- 1/15/2026 1:40:30 PM
- Kaiser Permanente has reached a settlement agreement with the U.S. Department of Justice to resolve a dispute regarding certain documentation practices impacting some Medicare Advantage risk adjustment submissions between 2009 and 2018.
- Updated WHO manuals provide guidance to strengthen foodborne disease surveillance and response capacities worldwide
- 1/15/2026 1:38:31 PM
- When a food safety incident is identified, INFOSAN members must act quickly. Timely detection, clear information, and coordinated response determine whether an event remains local or becomes an international emergency.
- AMA statement on restoring federal grants for mental health and SUD care
- 1/15/2026 1:07:54 PM
- Statement attributable to: David H. Aizuss, MD Chair, AMA Board of Trustees “The American Medical Association (AMA) is pleased that critical federal funding for mental health and addiction programs is being restored.
- New Anti-Inflammatory Lifestyle Guide Helps Adults Boost Energy, Sleep Better, Move Easier, and Age Stronger
- 1/15/2026
- Many adults are discovering that fatigue, brain fog, joint stiffness, sleep disruption, digestive discomfort, stubborn weight gain, and hormonal shifts are not simply signs of aging.
- Novel Liquid Biopsy Technology Lowers Barriers for More Efficient Cancer Diagnostics
- 1/14/2026 1:15:16 PM
- A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple workflow.
- Cardinal Health introduces ContinuCare™ Pathway; announces relationship with Publix
- 1/14/2026 11:48:16 AM
- Cardinal Health (NYSE: CAH) introduced ContinuCare™ Pathway, a unique pharmacy-to-supplier referral pathway program designed to help retail pharmacies seamlessly refer patients to Cardinal Health at-Home Solutions for the rapid fulfillment and direct-to-patient home delivery of diabetes supplies covered under the medical benefit, including continuous glucose monitors.
- Closing of the DIG Airgas acquisition: Air Liquide becomes the industrial gas leader in the dynamic South Korean market
- 1/14/2026 6:58:14 AM
- Air Liquide announces the successful completion of the DIG Airgas acquisition, a leading integrated gas player in South Korea. This marks a new significant milestone for the Group, 10 years after the major acquisition of Airgas in the United States.
- AMA announces recipients of $12 million precision education grant program
- 1/13/2026 12:42:15 PM
- The American Medical Association (AMA) today announced the recipients of $12 million in grant funding aimed at modernizing how physicians learn across their career.
- Cheaper drinks will see a rise in noncommunicable diseases and injuries
- 1/13/2026 12:19:28 PM
- Sugary drinks and alcoholic beverages are getting cheaper, due to consistently low tax rates in most countries, fueling obesity, diabetes, heart disease, cancers and injuries, especially in children and young adults.
- FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
- 1/12/2026 3:15:25 PM
- The U.S. Food and Drug Administration announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies (CGT).
- Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia
- 1/12/2026 3:03:48 PM
- Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced that its spin-out company, Neurosterix, has started a Phase 1 clinical study of NTX-253.
- AMA 2025 report on substance use and treatment
- 1/12/2026 2:40:07 PM
- The American Medical Association (AMA) today released its 2025 report (PDF) on the nation’s overdose epidemic, showing that while opioid-related overdose deaths declined last year, the epidemic remains widespread and increasingly complex, driven by mixing opioids and other substances and an unpredictable illicit drug supply. Overdose deaths declined from more than 110,000 …
- Why are men more likely to develop multiple myeloma than women?
- 1/12/2026 2:10:18 PM
- Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as high in men than in women. A new study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, provides insights that may help to explain this disparity.
- New Book Reveals a Science-Based Six-Step Plan to Calm Chronic Inflammation — Without Extreme Diets or Medications
- 1/12/2026
- Chronic inflammation has become a major contributor to many of the health struggles adults face today, including persistent fatigue, joint stiffness, sleep disruption, digestive challenges, brain fog, hormonal changes, and accelerated aging.
- Johnson & Johnson celebrates innovation in cancer research with 2025 Dr. Paul Janssen Award
- 1/8/2026 3:34:15 PM
- Johnson & Johnson today announced Tony Hunter, Ph.D., of the Salk Institute as the recipient of the 2025 Dr. Paul Janssen Award for Biomedical Research.
- New Year, New Healthy Habits: Sesame Workshop and Abbott Debut New Resources to Help Children and Families Build Healthy Habits Early
- 1/8/2026 2:15:16 PM
- Join Elmo, Grover, and friends, with special guest Aubrey Plaza as Ms. Noodle, as they host a supersized dance party in the new YouTube special Elmo’s World: Dance Party! premiering today in the United States, and rolling out in India, Mexico, and Brazil in the next few weeks.
- AMA applauds Dietary Guidelines, announces commitments on nutrition
- 1/8/2026 2:03:16 PM
- The following statement is attributable to: Bobby Mukkamala, MD President, American Medical Association “The American Medical Association (AMA) applauds the Administration’s new Dietary Guidelines for spotlighting the highly processed foods, sugar-sweetened beverages, and excess sodium that fuel heart disease, diabetes, obesity, and other chronic illnesses.
- Topos Bio Secures $10.5M to Tackle ‘Undruggable’ Proteins Driving Alzheimer’s and Cancer
- 1/8/2026 12:05:13 PM
- Topos Bio, a biotechnology company pioneering AI-driven drug discovery for intrinsically disordered proteins (IDPs), today emerged from stealth with $10.5M in seed funding from Boldstart, Threshold, and Neo, with participation from notable angel investors including Dara Khosrowshahi (CEO of Uber) and Naveen Rao (CEO of Unconventional AI).
- Bausch + Lomb to Present New Real-World Outcomes on Zenlens® Scleral Lenses at Global Specialty Lens Symposium
- 1/7/2026 7:59:51 PM
- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced that it will present new real-world outcomes on Zenlens scleral lenses during four presentations, including one oral presentation, at the Global Specialty Lens Symposium, taking place Jan.